Cadrenal Therapeutics 뉴스 - CVKD

기업명	주식 심볼	시장	주식 타입
Cadrenal Therapeutics Inc	CVKD	나스닥	보통주

	가격 변동	가격 변동 %	주식 가격	최근 거래 시간
	-0.0003	-0.07%	0.4402	21:00:01

개장가	저가	고가	종가	전일 종가
				0.4405

시세 정보 더보기 »

최근 뉴스

일자	시간	출처	제목
09/05/2024	22:00	PRNUS	Cadrenal Therapeutics Provides First Quarter 2024 Corporate..
09/05/2024	19:23	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/04/2024	05:30	PRNUS	Cadrenal Therapeutics to Participate in Noble Capital..
09/04/2024	22:00	PRNUS	Cadrenal Therapeutics Receives FDA Orphan Drug Designation..
11/03/2024	22:15	EDGAR2	Form 8-K - Current report
11/03/2024	22:00	PRNUS	Cadrenal Therapeutics Provides Fourth Quarter 2023 Corporate..
06/03/2024	07:24	EDGAR2	Form 8-K - Current report
26/02/2024	23:00	PRNUS	Cadrenal Therapeutics to Participate at Technology and Heart..
15/02/2024	22:00	EDGAR2	Form 8-K/A - Current report: [Amend]
13/02/2024	06:49	EDGAR2	Form 8-K - Current report
08/02/2024	23:00	PRNUS	Cadrenal Therapeutics Appoints Jeff Cole as Chief Operating..
31/01/2024	23:00	PRNUS	Cadrenal Therapeutics Highlights Publication of..
24/01/2024	23:00	PRNUS	Cadrenal Therapeutics to Participate in a Fireside Chat at..
04/01/2024	23:00	PRNUS	Cadrenal Therapeutics to Present at the Biotech Showcase on..
19/12/2023	23:00	PRNUS	Noble Capital Markets Initiates Coverage on Cadrenal..
12/12/2023	23:00	PRNUS	Cadrenal Therapeutics Engages The Sage Group to Advance..
01/12/2023	06:15	PRNUS	Cadrenal Therapeutics to Present at the NobleCon 19..
09/11/2023	23:15	EDGAR2	Form 8-K - Current report
09/11/2023	23:00	PRNUS	Cadrenal Therapeutics Provides Third Quarter 2023 Corporate..
09/11/2023	22:00	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
24/10/2023	06:04	EDGAR2	Form 8-K - Current report
10/10/2023	05:15	PRNUS	Cadrenal Therapeutics to Participate in the Lytham Partners..
09/09/2023	05:10	EDGAR2	Form 8-K - Current report
05/09/2023	21:00	PRNUS	Cadrenal Therapeutics Highlights Additional Need for a New..
01/09/2023	05:05	EDGAR2	Form DEFA14A - Additional definitive proxy soliciting..
01/09/2023	05:05	EDGAR2	Form DEFA14A - Additional definitive proxy soliciting..
30/08/2023	21:00	PRNUS	Cadrenal Therapeutics Expands Evaluation of Tecarfarin for..
29/08/2023	05:58	EDGAR2	Form ARS - Annual Report to Security Holders
29/08/2023	05:55	EDGAR2	Form DEF 14A - Other definitive proxy statements
29/08/2023	05:15	PRNUS	Cadrenal Therapeutics to Participate in the H.C. Wainwright..
18/08/2023	19:06	EDGAR2	Form 8-K - Current report
17/08/2023	05:10	EDGAR2	Form 8-K - Current report
17/08/2023	05:05	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
10/08/2023	22:16	EDGAR2	Form 8-K - Current report
10/08/2023	22:00	PRNUS	Cadrenal Therapeutics Provides Second Quarter 2023 Corporate..
10/08/2023	19:06	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/08/2023	22:00	PRNUS	Cadrenal Therapeutics Expands Focus for Tecarfarin to..
01/08/2023	19:06	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
24/07/2023	22:20	EDGAR2	Form 8-K - Current report
24/07/2023	22:15	EDGAR2	Form S-1 - General form for registration of securities under..
24/07/2023	22:00	PRNUS	Cadrenal Therapeutics Announces Appointment of Robert..
15/07/2023	05:52	EDGAR2	Form 8-K - Current report
15/07/2023	04:02	PRNUS	Cadrenal Therapeutics Announces Closing of $7.5 Million..
13/07/2023	04:17	PRNUS	Cadrenal Therapeutics Announces $7.5 Million Private..
01/06/2023	22:00	PRNUS	Cadrenal Therapeutics to Participate in the 2023 BIO..

이 » 주식의 기사 더보기;

시장 데이터

뉴스

도구

시장

팔로우

Hot Features

피드 팔로우

실시간 옵션 플로우

모니터

CVKD Cadrenal Therapeutics Inc

최근 뉴스

CVKD 과거 데이터 - 1일

CVKD 과거 데이터 - 1년

최근 히스토리

회사 소개

사업

Popular

앱 받기

시장 데이터

뉴스

도구

시장

팔로우

Hot Features

피드 팔로우

실시간 옵션 플로우

모니터

Cadrenal Therapeutics Inc (CVKD) 뉴스

CVKD Cadrenal Therapeutics Inc

최근 뉴스

CVKD 과거 데이터 - 1일

CVKD 과거 데이터 - 1년

최근 히스토리

회사 소개

사업

Popular

앱 받기